C2 Adamantanyl galactosylceramide (d18:1/2:0)

Overview

C2 Adamantanyl galactosylceramide (AdaGalCer) (d18:1/2:0) is a bioactive sphingolipid. C2 Adamantanyl galactosylceramide (d18:1/2:0) stimulates glucocerebrosidase activity in vitro. C2 Adamantanyl galactosylceramide (d18:1/2:0) inhibits microsomal LacCer and Gb 3 synthase , and inhibits cell sulfatide synthesis. C2 Adamantanyl galactosylceramide (d18:1/2:0) reduces glucosylceramide (GlcCer) levels in normal and lysosomal storage disease (LSD) cells. C2 Adamantanyl galactosylceramide (d18:1/2:0) acts as a substrate for A4GALT and is able to lower Gb 3 levels with an IC 50 concentration of 40 μM in fabry disease cells.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Epigenetics | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Glycosidase | Products > Signaling Pathways > Glucosylceramide Synthase (GCS) | Products > Signaling Pathways > Glycosyltransferase

Product Information

• Catalog No.: HY-156208
• CAS No.: 574738-16-2
• Molecular Formula: C36H63NO8
• Molecular Weight: 637.89
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source